Siepmann, F.
Inserm,
France
2024 Rank: 190166
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Polymers
Rank in SubField 1: 1419 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 190166 | 204034 |
| Total Cites | 649 | 720 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 36 | 36 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 319 | 329 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 479 | 498 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.45 |
| Self-Citation Percentage |
9.86%
|
|
Siepmann, F.
Médicaments et Biomatériaux à Libération Contrôlée : Mécanismes et Optimisation (MBLC),
France
2023 Rank: 251820
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Polymers
Rank in SubField 1: 2021 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 251820 | 251844 |
| Total Cites | 515 | 569 |
| H-index | 9 | 10 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 35 | 35 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 277 | 289 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 412 | 429 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.33 |
| Self-Citation Percentage |
9.49%
|
|
Siepmann, F.
Université de Lille,
France
2022 Rank: 157759
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Polymers
Rank in SubField 1: 1162 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157759 | 157316 |
| Total Cites | 611 | 680 |
| H-index | 10 | 11 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 56 | 64 |
| Number of Single+First+Last Authored Papers | 42 | 42 |
| Total Cites to Single+First+Last Authored Papers | 336 | 364 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 446 | 462 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.47 |
| Self-Citation Percentage |
10.15%
|
|
Siepmann, F.
Université de Lille,
France
2021 Rank: 157138
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Polymers
Rank in SubField 1: 1181 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157138 | 164656 |
| Total Cites | 909 | 995 |
| H-index | 13 | 13 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 17 | 17 |
| Total Cites to Single+First Authored Papers | 87 | 93 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 512 | 548 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 691 | 717 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.39 |
| Self-Citation Percentage |
8.64%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.